AHR 2016: The aryl hydrocarbon receptor as a central mediator of health and disease

AHR 2016：芳烃受体作为健康和疾病的中心介质

• 批准号: 9121735
• 负责人: B Paige Lawrence
• 金额: $ 1万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2017-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9121735
• 关键词: Address; Applied Research; Area; Aryl Hydrocarbon Receptor; Attention; Basic Science; Biological Process; Clinical; Clinical Medicine; Collaborations; Communities; Consensus; Development; Developmental Biology; Disabled Persons; Disadvantaged; Discipline; Disease; Doctor of Philosophy; Ensure; Environmental Health; Environmental Medicine; Environmental Pollution; Fertilization; Fostering; Foundations; Funding; Future; Germany; Goals; Grant; Health; Human; Immunology; Interdisciplinary Communication; International; Knowledge; Ligands; Mediator of activation protein; Minority; Minority Groups; Molecular; National Institute of Environmental Health Sciences; Oral; Output; Participant; Personal Satisfaction; Pharmacology; Pharmacy (field); Postdoctoral Fellow; Public Health; Publishing; Regulation; Request for Applications; Research; Research Personnel; Research Priority; Role; Science; Scientist; Source; Students; Thinking; Toxic effect; Toxicology; Universities; Woman; abstracting; aryl hydrocarbon receptor ligand; base; improved; interest; meetings; multidisciplinary; posters; prevent; programs; public health relevance; rapid growth; symposium; translational approach

 DESCRIPTION (provided by applicant): This application requests funds to support an international conference entitled "AHR 2016: The aryl hydrocarbon receptor as a central mediator of health and disease" which will be in Rochester, NY in August 3-6, 2016. Specifically, funds from this R13 application to the NIEHS will be used to support disadvantaged poorly represented and/or junior investigators who submit research abstracts and wish to participate in the meeting, but who otherwise might not be able to attend. Their participation will undoubtedly strengthen the conference and the field as a whole. This conference covers a topic that is highly relevant to toxicology and environmental health sciences, and which is also gaining tremendous attention from other sectors, including basic immunology, developmental biology, pharmacology, and pharmaceutics. However, there are no regular (or as far as we know, planned) scientific conferences focused solely on the AHR. Given the rapid but poorly integrated advancements in the field, there is pressing need to bring together toxicologists, basic biologists, and clinical/translational researchers who are all interested in the AHR and its many ligands? Therefore, in addition to fostering the participation of junior investigators, women, minority groups, and the disabled, other goals of this conference include the following: promoting greater interactions among scientists of diverse backgrounds; creating the opportunity to discuss cutting-edge science, and building the foundation for cross- disciplinary communication and collaborations to advance the field. This conference will advance the pace of science by identifying key knowledge gaps and developing strategies to address them, pinpointing critical implications for environmental health and clinical medicine, and building consensus for addressing specific research priorities that relate to these issues. As a consequence of these goals, the meeting is expected to promulgate cutting-edge information that will catalyze new discoveries to improve health and well-being. Also, as a more tangible output, the Organizing Committee plans to develop a review article to be submitted after this conference. Based upon meeting attendance, presentations, and discussion, the organizers will assess the potential for a more expanded set of research and/or review articles based on this conference, as well as evaluate the potential for a future conference on this topic.

 描述(申请人提供)：本申请申请资助将于2016年8月3日至6日在纽约州罗切斯特市举行的题为“AHR 2016：芳香烃受体作为健康和疾病的中心介体”的国际会议。具体地说，向NIEHS申请R13的资金将用于支持代表人数较少的弱势群体和/或初级调查人员，他们提交研究摘要并希望参加会议，但可能无法参加会议。他们的参与无疑将加强会议和整个实地。这次会议涵盖了一个与毒理学和环境健康科学高度相关的主题，也受到了基础免疫学、发育生物学、药理学和药剂学等其他部门的极大关注。然而，目前还没有专门针对AHR的定期(或据我们所知，有计划的)科学会议。鉴于该领域的快速但缺乏整合的进展，迫切需要将毒理学家、基础生物学家和临床/翻译研究人员聚集在一起，他们都对AHR及其众多配体感兴趣？因此，除了促进初级研究人员、妇女、少数群体和残疾人的参与外，这次会议的其他目标还包括：促进不同背景的科学家之间更多的互动；创造机会讨论尖端科学，并为跨学科交流和合作奠定基础，以推动该领域的发展。这次会议将通过确定关键的知识差距并制定战略来解决这些差距，查明对环境健康和临床医学的关键影响，并就解决与这些问题有关的具体研究优先事项达成共识，从而推进科学的步伐。作为这些目标的结果，会议预计将公布尖端信息，这些信息将催化新的发现，以改善健康和福祉。此外，作为一项更切实的成果，组委会计划编写一篇审查文章，在本次会议之后提交。根据会议出席率、演讲和讨论，组织者将评估基于本次会议的更多研究和/或评论文章的潜力，以及评估未来就这一主题举行会议的可能性。